Bill

Bill > HB1143


GA HB1143

GA HB1143
Menstrual Product Transparency and Safety Act of 2026; enact


summary

Introduced
02/02/2026
In Committee
Crossed Over
Passed
Dead

Introduced Session

2025-2026 Regular Session

Bill Summary

AN ACT To amend Chapter 1 of Title 31 of the Official Code of Georgia Annotated, relating to general provisions regarding health, so as to provide for safer menstrual products in this state; to provide for definitions; to prohibit restricted substances in menstrual products; to provide for the Department of Public Health to identify restricted substances, establish allowable trace thresholds, and provide for a phased compliance schedule; to require ingredient labeling on packages or boxes; to require third-party testing of ingredients; to provide for public disclosure of such testing results; to provide for a civil penalty; to require the Department of Public Health to establish a public education campaign; to provide for periodic review; to provide for related matters; to provide for a short title; to repeal conflicting laws; and for other purposes.

AI Summary

This bill, known as the Menstrual Product Transparency and Safety Act of 2026, aims to ensure safer menstrual products are available in Georgia by prohibiting certain harmful chemicals, referred to as "restricted substances," from being intentionally added to these products, which include items like tampons, pads, and menstrual cups. The Georgia Department of Public Health will be responsible for identifying these restricted substances, such as lead, mercury, formaldehyde, and PFAS (per- and polyfluoroalkyl substances, a group of man-made chemicals), and will also establish "allowable trace thresholds," which are the maximum acceptable levels of these substances if they are not intentionally added but are present in very small amounts. Manufacturers will be required to list all ingredients on product packaging starting July 1, 2027, and will also need to conduct independent "third-party testing" to verify the safety of these ingredients, with the results publicly disclosed on their websites. The bill also mandates a phased compliance schedule for manufacturers, a civil penalty of up to $1,000 per package for violations, and a public education campaign by the Department of Public Health to inform consumers about ingredient labels and potential health risks.

Committee Categories

Health and Social Services

Sponsors (5)

Last Action

House Second Readers (on 02/04/2026)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...